Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries
Aim: The purpose of this viewpoint is to summarize the advantages and constraints of the tools and strategies available for reducing the annual incidence of tuberculosis (TB) by implementing the World Health Organization (WHO) End TB Strategy and the linked WHO TB Elimination Framework, with special...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220301004 |
id |
doaj-a8740dc74e7c4148893f0c7ad6f42054 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Seif Al Abri Thereza Kasaeva Giovanni Battista Migliori Delia Goletti Dominik Zenner Justin Denholm Amal Al Maani Daniela Maria Cirillo Thomas Schön Troels Lillebæk Amina Al-Jardani Un-Yeong Go Hannah Monica Dias Simon Tiberi Fatma Al Yaquobi Faryal Ali Khamis Padmamohan Kurup Michael Wilson Ziad Memish Ali Al Maqbali Muhammad Akhtar Christian Wejse Eskild Petersen |
spellingShingle |
Seif Al Abri Thereza Kasaeva Giovanni Battista Migliori Delia Goletti Dominik Zenner Justin Denholm Amal Al Maani Daniela Maria Cirillo Thomas Schön Troels Lillebæk Amina Al-Jardani Un-Yeong Go Hannah Monica Dias Simon Tiberi Fatma Al Yaquobi Faryal Ali Khamis Padmamohan Kurup Michael Wilson Ziad Memish Ali Al Maqbali Muhammad Akhtar Christian Wejse Eskild Petersen Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries International Journal of Infectious Diseases |
author_facet |
Seif Al Abri Thereza Kasaeva Giovanni Battista Migliori Delia Goletti Dominik Zenner Justin Denholm Amal Al Maani Daniela Maria Cirillo Thomas Schön Troels Lillebæk Amina Al-Jardani Un-Yeong Go Hannah Monica Dias Simon Tiberi Fatma Al Yaquobi Faryal Ali Khamis Padmamohan Kurup Michael Wilson Ziad Memish Ali Al Maqbali Muhammad Akhtar Christian Wejse Eskild Petersen |
author_sort |
Seif Al Abri |
title |
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries |
title_short |
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries |
title_full |
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries |
title_fullStr |
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries |
title_full_unstemmed |
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries |
title_sort |
tools to implement the world health organization end tb strategy: addressing common challenges in high and low endemic countries |
publisher |
Elsevier |
series |
International Journal of Infectious Diseases |
issn |
1201-9712 |
publishDate |
2020-03-01 |
description |
Aim: The purpose of this viewpoint is to summarize the advantages and constraints of the tools and strategies available for reducing the annual incidence of tuberculosis (TB) by implementing the World Health Organization (WHO) End TB Strategy and the linked WHO TB Elimination Framework, with special reference to Oman. Methods: The case-study was built based on the presentations and discussions at an international workshop on TB elimination in low incidence countries organized by the Ministry of Health, Oman, which took place from September 5 to September 7, 2019, and supported by the WHO and European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Results: Existing tools were reviewed, including the screening of migrants for latent TB infection (LTBI) with interferon-gamma release assays, clinical examination for active pulmonary TB (APTB) including chest X-rays, organization of laboratory services, and the existing centres for mandatory health examination of pre-arrival or arriving migrants, including examination for APTB. The need for public–private partnerships to handle the burden of screening arriving migrants for active TB was discussed at length and different models for financing were reviewed. Conclusions: In a country with a high proportion of migrants from high endemic countries, screening for LTBI is of high priority. Molecular typing and the development of public–private partnerships are needed. Keywords: Tuberculosis, Control, Prevention, Latent TB infection, Care, Screening, Migrants |
url |
http://www.sciencedirect.com/science/article/pii/S1201971220301004 |
work_keys_str_mv |
AT seifalabri toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT therezakasaeva toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT giovannibattistamigliori toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT deliagoletti toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT dominikzenner toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT justindenholm toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT amalalmaani toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT danielamariacirillo toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT thomasschon toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT troelslillebæk toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT aminaaljardani toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT unyeonggo toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT hannahmonicadias toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT simontiberi toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT fatmaalyaquobi toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT faryalalikhamis toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT padmamohankurup toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT michaelwilson toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT ziadmemish toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT alialmaqbali toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT muhammadakhtar toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT christianwejse toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries AT eskildpetersen toolstoimplementtheworldhealthorganizationendtbstrategyaddressingcommonchallengesinhighandlowendemiccountries |
_version_ |
1725286451187286016 |
spelling |
doaj-a8740dc74e7c4148893f0c7ad6f420542020-11-25T00:41:14ZengElsevierInternational Journal of Infectious Diseases1201-97122020-03-0192S60S68Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countriesSeif Al Abri0Thereza Kasaeva1Giovanni Battista Migliori2Delia Goletti3Dominik Zenner4Justin Denholm5Amal Al Maani6Daniela Maria Cirillo7Thomas Schön8Troels Lillebæk9Amina Al-Jardani10Un-Yeong Go11Hannah Monica Dias12Simon Tiberi13Fatma Al Yaquobi14Faryal Ali Khamis15Padmamohan Kurup16Michael Wilson17Ziad Memish18Ali Al Maqbali19Muhammad Akhtar20Christian Wejse21Eskild Petersen22Directorate General for Diseases Surveillance and Control, Ministry of Health, Muscat, Oman; Corresponding author.WHO Global TB Programme, Geneva, SwitzerlandServizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, ItalyTranslational Research Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani” — IRCCS, Rome, Italy; ESCMID Study Group on Mycobacteria, Basel, SwitzerlandRegional Office of the European Economic Area, EU and NATO and International Organization for Migration, IOM, Brussels, BelgiumDepartment of Infectious Diseases, Royal Melbourne Hospital and Victorian TB Programme, Melbourne, AustraliaPaediatric Infectious Diseases, The Royal Hospital and Central Department of Infection Prevention and Control, Directorate General for Diseases Surveillance and Control, Ministry of Health, Muscat, OmanEmerging Bacterial Pathogen Research Unit, Italian Reference Centre for Molecular Typing of Mycobacteria, San Rafaele Scientific Institute, Milan, ItalyDepartment of Clinical Microbiology and Infectious Diseases, Kalmar Hospital and University of Linköping, SwedenInternational Reference Laboratory of Mycobacteriology, WHO TB Supranational Reference Laboratory Copenhagen, Infectious Disease Preparedness Area, Statens Serum Institute and Global Health Section, Department of Public Health, University of Copenhagen, Copenhagen, DenmarkCentral Public Health Laboratory, Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, OmanInternational Tuberculosis Research Centre, Seoul, Republic of KoreaWHO Global TB Programme Unit on Policy, Strategy and Innovations, Geneva, SwitzerlandInfectious Diseases, Barts Health NHS Trust, London, United Kingdom; Queen Mary University of London, London, United KingdomTuberculosis and Acute Respiratory Diseases Surveillance, Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, OmanDepartment of Infectious Diseases, The Royal Hospital, Ministry of Health, Muscat, OmanDepartment of Disease Surveillance and Control, Muscat Governorate, Muscat, OmanZero TB Initiative, Durban, South AfricaPrince Mohammed bin Abdulaziz Hospital, Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Rollings School of Public Health, Emory University, Atlanta, GA, USADisease Surveillance and Control, North Bathinah Governorate, Sohar, OmanWHO MENA Region TB Programme, Cairo, EgyptDepartment of Infectious Disease, Aarhus University Hospital and School of Public Health, Faculty of Health Sciences, University of Aarhus, Denmark; ESCMID Study Group for Travel and Migration, Basel, SwitzerlandDirectorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman; Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark; ESCMID Emerging Infections Task Force, Basel, SwitzerlandAim: The purpose of this viewpoint is to summarize the advantages and constraints of the tools and strategies available for reducing the annual incidence of tuberculosis (TB) by implementing the World Health Organization (WHO) End TB Strategy and the linked WHO TB Elimination Framework, with special reference to Oman. Methods: The case-study was built based on the presentations and discussions at an international workshop on TB elimination in low incidence countries organized by the Ministry of Health, Oman, which took place from September 5 to September 7, 2019, and supported by the WHO and European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Results: Existing tools were reviewed, including the screening of migrants for latent TB infection (LTBI) with interferon-gamma release assays, clinical examination for active pulmonary TB (APTB) including chest X-rays, organization of laboratory services, and the existing centres for mandatory health examination of pre-arrival or arriving migrants, including examination for APTB. The need for public–private partnerships to handle the burden of screening arriving migrants for active TB was discussed at length and different models for financing were reviewed. Conclusions: In a country with a high proportion of migrants from high endemic countries, screening for LTBI is of high priority. Molecular typing and the development of public–private partnerships are needed. Keywords: Tuberculosis, Control, Prevention, Latent TB infection, Care, Screening, Migrantshttp://www.sciencedirect.com/science/article/pii/S1201971220301004 |